Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer

Table 1

The 11 small-molecule drugs of CMP database analysis.

cmap name	Mean		Enrichment	value	Percent nonnull
Vorinostat	-0.766	2	-0.995	0.00008	100
Cinchonine	-0.697	2	-0.983	0.00058	100
Helveticoside	-0.83	2	-0.982	0.0007	100
Lanatoside C	-0.818	2	-0.981	0.00082	100
Idoxuridine	-0.64	2	-0.963	0.00304	100
Niclosamide	-0.621	2	-0.959	0.00368	100
Ampicillin	-0.607	2	-0.958	0.0038	100
Epitiostanol	-0.595	2	-0.952	0.00497	100
Tiapride	-0.652	2	-0.972	0.00159	100
Pyrimethamine	-0.57	2	-0.935	0.00891	100
Cephaeline	-0.521	2	-0.879	0.00347	100